Quotables
"That the automobile has practically reached the limit of its development is suggested by the fact that during the past year no improvements of a radical nature have been introduced."
Scientific American ; Jan. 2 edition, 1909
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7989436 | Estrogenic compounds and pharmaceutical formulations comprising the same Novel estrogenic compounds of Formula I are provided. wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected from the group cons... | 08/02/2011 |
| 7749989 | Estrogenic compounds, methods of using and methods of administering the same Novel estrogenic compounds of Formula I are provided. wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected from the group cons... | 07/06/2010 |
| 7459445 | Estrogenic compounds and topical pharmaceutical formulations of the same Novel estrogenic compounds of Formula I are provided. wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected from the group cons... | 12/02/2008 |
| 7320969 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressan... | 01/22/2008 |
| 7005138 | Method of systematically delivering SSRIs Methods and compositions are disclosed for the intravaginal or rectal delivery of selected serotonin reuptake inhibitors (SSRIs) to the systemic circulation. Such methods and compositions are useful in the treatment of depression, migraine headaches, chronic pain, p... | 02/28/2006 |
| 6346268 | Sustained release formulation containing three different types of polymers and tablet formed therefrom Depot drug formulations include the pharmaceutical itself and a three component release rate controlling matrix composition. The three components of the matrix composition are (1) a pH dependent gelling polymer such as an alginate component, (2) an enteri... | 02/12/2002 |
| 6083532 | Sustained release formulation containing three different types of polymers and tablet formed therefrom Depot drug formulations include the pharmaceutical itself and a three component release rate controlling matrix composition. The three components of the matrix composition are (1) a pH dependent gelling polymer such as an alginate component, (2) an enteri... | 07/04/2000 |
| 5908638 | Pharmaceutical compositions of conjugated estrogens and methods for their use This invention relates to novel pharmaceutical compositions and methods for their preparation containing conjugated estrogens for the treatment of peri-menopausal, menopausal and post-menopausal disorders in women. The novel pharmaceutical compositions co... | 06/01/1999 |
